Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress
Authors
Keywords
Isorhamnetin, Liver fibrosis, Hepatic stellate cells, TGF-β, Smad, Oxidative stress
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 783, Issue -, Pages 92-102
Publisher
Elsevier BV
Online
2016-05-04
DOI
10.1016/j.ejphar.2016.04.042

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.